Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-07 Purchase | 2023-06-08 07:00 am | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 14,000 | $0.6931 | $9,703 | 250,000 (Direct) | View |
| 2023-06-06 Purchase | 2023-06-07 07:00 am | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 26,000 | $0.6328 | $16,453 | 236,000 (Direct) | View |
| 2023-02-10 Purchase | 2023-02-13 06:06 am | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 25,000 | $1.043 | $26,075 | 210,000 (Direct) | View |
| 2023-02-02 Purchase | 2023-02-03 06:02 am | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 25,000 | $0.9405 | $23,513 | 185,000 (Direct) | View |
| 2023-01-25 Purchase | 2023-01-26 06:03 am | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 25,000 | $0.873 | $21,825 | 160,000 (Direct) | View |
| 2023-01-20 Purchase | 2023-01-23 06:08 am | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 25,000 | $0.7482 | $18,705 | 135,000 (Direct) | View |
| 2022-12-29 Purchase | 2023-01-03 06:04 am | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 100,000 | $0.437 | $43,700 | 110,000 (Direct) | View |
| 2021-05-10 Purchase | 2021-05-10 5:30 pm | Synthetic Biologics Inc. | SYN | SHALLCROSS STEVEN A CEO and CFO | 50,000 | $0.4919 | $24,595 | 100,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-14 Option Award | 2023-12-15 4:07 pm | 2024-01-14 2030-12-14 | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 700,000 | $0 | 700,000 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-15 4:01 pm | 2024-01-14 2030-12-14 | Theriva Biologics Inc. | TOVX | Wolf Jeffrey Alan Director | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-15 4:00 pm | 2024-01-14 2030-12-14 | Theriva Biologics Inc. | TOVX | Kraws Jeffrey J Director | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-15 4:00 pm | 2024-01-14 2030-12-14 | Theriva Biologics Inc. | TOVX | MONAHAN JOHN J Director | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-16 6:17 pm | 2023-01-15 2029-12-15 | Theriva Biologics Inc. | TOVX | Kraws Jeffrey J Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-16 6:17 pm | 2023-01-15 2029-12-15 | Theriva Biologics Inc. | TOVX | Wolf Jeffrey Alan Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-16 6:17 pm | 2023-01-15 2029-12-15 | Theriva Biologics Inc. | TOVX | MONAHAN JOHN J Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-16 6:16 pm | 2023-01-15 2029-12-15 | Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO | 475,000 | $0 | 475,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-16 6:16 pm | 2023-01-15 2029-12-15 | Theriva Biologics Inc. | TOVX | Tufaro Francis Chief Operating Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2022-03-23 6:03 pm | N/A N/A | Synthetic Biologics Inc. | SYN | Tufaro Francis Chief Operating Officer | 0 | $0 | 806,452 (Direct) | View |
| 2021-12-23 Option Award | 2021-12-27 5:09 pm | 2022-01-23 2028-12-23 | Synthetic Biologics Inc. | SYN | Wolf Jeffrey Alan Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-12-23 Option Award | 2021-12-27 5:06 pm | 2022-01-23 2028-12-23 | Synthetic Biologics Inc. | SYN | SHALLCROSS STEVEN A CEO and CFO | 650,000 | $0 | 650,000 (Direct) | View |
| 2021-12-23 Option Award | 2021-12-27 5:05 pm | 2022-01-23 2028-12-23 | Synthetic Biologics Inc. | SYN | MONAHAN JOHN J Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-12-23 Option Award | 2021-12-27 5:03 pm | 2022-01-23 2028-12-23 | Synthetic Biologics Inc. | SYN | Kraws Jeffrey J Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-12-30 Option Award | 2020-12-31 4:31 pm | 2021-01-30 2027-12-30 | Synthetic Biologics Inc. | SYN | Wolf Jeffrey Alan Director | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-12-30 Option Award | 2020-12-31 4:30 pm | 2021-01-30 2027-12-30 | Synthetic Biologics Inc. | SYN | SHALLCROSS STEVEN A CEO and CFO | 450,000 | $0 | 450,000 (Direct) | View |
| 2020-12-30 Option Award | 2020-12-31 4:30 pm | 2021-01-30 2027-12-30 | Synthetic Biologics Inc. | SYN | MONAHAN JOHN J Director | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-12-30 Option Award | 2020-12-31 4:30 pm | 2021-01-30 2027-12-30 | Synthetic Biologics Inc. | SYN | Kraws Jeffrey J Director | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2020-11-12 3:39 pm | 2011-12-19 2021-12-18 | Synthetic Biologics Inc. | SYN | MONAHAN JOHN J Director | 0 | $0 | 27,358 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-06 07:13 am | 2019-12-04 2026-12-04 | Synthetic Biologics Inc. | SYN | Tarriff Scott Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-06 07:13 am | 2019-12-04 2026-12-04 | Synthetic Biologics Inc. | SYN | Kraws Jeffrey J Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-05 4:55 pm | 2019-12-04 2026-12-04 | Synthetic Biologics Inc. | SYN | Wolf Jeffrey Alan Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-05 4:54 pm | 2019-12-04 2026-12-04 | Synthetic Biologics Inc. | SYN | SHALLCROSS STEVEN A CEO and CFO | 450,000 | $0 | 450,000 (Direct) | View |